New Treatments & Clinical Trials for Insomnia

Insomnia affects about one-third of adults at some point, with roughly 10% experiencing chronic sleep difficulty. Current treatment includes cognitive behavioral therapy for insomnia (CBT-I), which is considered first-line, plus medications like zolpidem and eszopiclone that help with sleep onset or maintenance but carry dependency risks.

What's actually going on in research

Trials are testing dual orexin receptor antagonists that block wake-promoting signals, drugs targeting circadian rhythm misalignment, and digital CBT-I platforms. Researchers are studying insomnia's links to Alzheimer's disease and metabolic health, and testing treatments for people whose insomnia doesn't respond to standard approaches.

What to know before you search

Eligibility typically depends on insomnia duration (chronic vs. short-term), severity measured by sleep diaries or questionnaires, whether you have other medical or psychiatric conditions, and current medication use.

What types of trials are currently open

• Medication trials — Testing new sleep medications, often comparing them to placebo or existing drugs like zolpidem. These typically measure how quickly you fall asleep and how long you stay asleep.
• Behavioral therapy trials — Testing digital or in-person CBT-I programs, often comparing different delivery methods or measuring long-term effectiveness.
• Combination trials — Testing whether pairing medication with CBT-I works better than either alone, especially for chronic insomnia.
• Device trials — Testing wearables, light therapy devices, or neurostimulation devices that aim to improve sleep quality or regulate circadian rhythms.
• Comorbidity trials — Studying insomnia treatments in people who also have depression, anxiety, chronic pain, or other conditions that disrupt sleep.